Development of an extemporaneous preparation formulation using a simple and non-solubilizing matrix for first in human clinical study-Reference-Cited by-同舟云学术

Development of an extemporaneous preparation formulation using a simple and non-solubilizing matrix for first in human clinical study

Published:2024-03 Issue: Volume:653 Page:123868
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Chiang Cheng W.,Tang Shijia^ORCID,Boonstra Jasper Martijn,van Tilburg Leon Pascal,Liu Jia,Chiang Po-Chang,Rich Sharyl^ORCID,Wu Newton^ORCID,Nguyen Huy Q.,Zhang Wei^ORCID,Hou Hao Helen,Leung Dennis H.

Funder

Genentech

Publisher

Elsevier BV

Reference27 articles.

1. Application and validation of an advanced gastrointestinal in vitro model for the evaluation of drug product performance in pharmaceutical development;Barker;J. Pharm. Sci.,2014

2. Evaluating the IVIVC by combining Tiny-Tim outputs and compartmental PK model to predict oral exposure for different formulations of ibuprofen;Chiang;J. Pharm. Sci.,2022

3. An investigation into the utility of a multi-compartmental, dynamic, system of the upper gastrointestinal tract to support formulation development and establish bioequivalence of poorly soluble drugs;Dickinson;AAPS J.,2012

4. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine;Dresser;Clin. Pharmacol. Ther.,2002

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide;Molecular Pharmaceutics;2024-06-05